홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium Iodide → (6R,7R)-3-[[5-amino-4-(3-aminopropylcarbamoylamino)-1-methylpyrazol-2-ium-2-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

HRID 1247792
인쇄

반응식

HRID 1247792 반응식
C(OC([NH:8][C:9]1[S:13][N:12]=[C:11](/[C:14](=[N:45]/[O:46][C:47]([C:50]([O:52]C(C)(C)C)=[O:51])([CH3:49])[CH3:48])/[C:15]([NH:17][C@@H:18]2[C:43](=[O:44])[N:20]3[C:21]([C:27]([O:29]C(C4C=CC=CC=4)C4C=CC=CC=4)=[O:28])=[C:22]([CH2:25]Cl)[CH2:23][S:24][C@H:19]23)=[O:16])[N:10]=1)=O)(C)(C)C.[I-].[Na+].[NH2:59][C:60]1[N:64]([CH3:65])[N:63]=[CH:62][C:61]=1[NH:66][C:67]([NH:69][CH2:70][CH2:71][CH2:72][NH:73]C(OC(C)(C)C)=O)=[O:68].C(OCC)(=O)C>CN(C)C=O.O>[NH2:8][C:9]1[S:13][N:12]=[C:11](/[C:14](=[N:45]/[O:46][C:47]([C:50]([OH:52])=[O:51])([CH3:48])[CH3:49])/[C:15]([NH:17][C@@H:18]2[C:43](=[O:44])[N:20]3[C:21]([C:27]([O-:29])=[O:28])=[C:22]([CH2:25][N+:63]4[N:64]([CH3:65])[C:60]([NH2:59])=[C:61]([NH:66][C:67]([NH:69][CH2:70][CH2:71][CH2:72][NH2:73])=[O:68])[CH:62]=4)[CH2:23][S:24][C@H:19]23)=[O:16])[N:10]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 5238Sodium IodideHCID 8857Ethyl AcetateHCID 219045935-Amino-4-(3-{3-[(tert-butoxycarbonyl)amino]propyl}ureido)-1-methylpyrazoleHCID 87787063benzhydryl (6R,7R)-3-(chloromethyl)-7-[[(2Z)-2-[2-methyl-1-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]oxyimino-2-[5-[(2-methylpropan-2-yl)oxycarbonylamino]-1,2,4-thiadiazol-3-yl]acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

생성물 1

HCID 141604764
(6R,7R)-3-[[5-amino-4-(3-aminopropylcarbamoylamino)-1-methylpyrazol-2-ium-2-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
수율 6.4%

시약·촉매·용매 2

HCID 962Water용매HCID 6228Dimethylformamide용매

실험 절차

To a solution of benzhydryl 7β-[(Z)-2-(5-tert-butoxycarbonylamino-1,2,4-thiadiazol-3-yl)-2-(1-tert-butoxycarbonyl-1-methylethoxyimino)acetamido]-3-chloromethyl-3-cephem-4-carboxylate (1.0 g) in N,N-dimethylformamide (2.0 ml) was added sodium iodide (199 mg), and the mixture was stirred at room temperature for 30 minutes. To the reaction mixture was added 5-amino-4-(3-{3-[(tert-butoxycarbonyl)amino]propy}ureido)-1-methylpyrazole (415 mg) and the whole mixture was stirred at 32° C. for 24 hours. To the resulting reaction mixture were added ethyl acetate (50 ml) and water (50 ml). The aqueous layer was separated, and the organic layer was washed with 10% aqueous sodium trifluoroacetate solution and brine, dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated to about 5 ml in vacuo. The concentrate was poured into diisopropyl ether (100 ml), and the resulting precipitate was collected by filtration and dried in vacuo. To a solution of the resulting solid in methylene chloride (3.6 ml) were added anisole (1.2 ml) and trifluoroacetic acid (2.4 ml). The resulting solution was stirred at room temperature for 4 hours and poured into diisopropyl ether (100 ml). The resulting precipitate was collected by filtration and dried in vacuo to give a crude product (939 mg), which was purified by preparative HPLC utilizing ODS column. The eluate containing a desired product was concentrated to about 30 ml in vacuo. The concentrate was adjusted to about pH 3 with concentrated hydrochloric acid and chromatographed on Diaion® HP-20 (Mitsubishi Chemical Corporation) eluting with 30% aqueous 2-propanol. The eluate was concentrated to about 30 ml in vacuo and lyophilized to give 7β-[(Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(1-carboxy-1-methylethoxyimino)acetamido]-3-{3-amino-4-[3-(3-aminopropyl)ureido]-2-methyl-1-pyrazolio}methyl-3-cephem-4-carboxylate (53 mg) as an amorphous solid.

후처리

  1. stirringthe whole mixture was stirred at 32° C. for 24 hours
  2. customTo the resulting reaction mixture
  3. customThe aqueous layer was separated
  4. washthe organic layer was washed with 10% aqueous sodium trifluoroacetate solution and brine
  5. dry with materialdried over anhydrous sodium sulfate
  6. filtrationfiltered
  7. concentrationThe filtrate was concentrated to about 5 ml in vacuo
  8. additionThe concentrate was poured into diisopropyl ether (100 ml)
  9. filtrationthe resulting precipitate was collected by filtration
  10. customdried in vacuo
  11. additionTo a solution of the resulting solid in methylene chloride (3.6 ml) were added anisole (1.2 ml) and trifluoroacetic acid (2.4 ml)
  12. stirringThe resulting solution was stirred at room temperature for 4 hours
  13. additionpoured into diisopropyl ether (100 ml)
  14. filtrationThe resulting precipitate was collected by filtration
  15. customdried in vacuo
  16. customto give a crude product (939 mg), which
  17. customwas purified by preparative HPLC
  18. additionThe eluate containing a desired product
  19. concentrationwas concentrated to about 30 ml in vacuo
  20. customchromatographed on Diaion®
  21. wash(Mitsubishi Chemical Corporation) eluting with 30% aqueous 2-propanol
  22. concentrationThe eluate was concentrated to about 30 ml in vacuo

출처 및 근거

ORD 기록
ord-41da638b1aec499d8073133051935032
출처 데이터셋
uspto-grants-2006_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07129232B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트